SMITH & NEPHEW, INC. UNKNOWN REGENETEN BIOINDUCTIVE IMPLANT SYSTEM DEV; MESH, SURGICAL, COLLAGEN, ORTHOPAEDICS, REINFORCEMENT OF TENDON
|
Back to Search Results |
|
Catalog Number UNKNOWN |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Fibrosis (3167)
|
Event Date 10/14/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Internal complaint reference: (b)(4).
|
|
Event Description
|
It was reported that after an arthroscopy procedure with a regeneten device, the patient experience a left shoulder arthrofibrosis.The event was treated with mua and it was resolved.
|
|
Manufacturer Narrative
|
Internal complaint reference (b)(4).H10: h3, h6: the reported device was not returned to the designated complaint unit for independent evaluation, thus visual inspection and functional testing could not be performed.Insufficient product identification information was provided and thus a manufacturing record, complaint history, device labeling/instructions for use and capa, nc, pra/hhe review could not be conducted.Based on the information available, there were no indications to suggest that the product did not meet manufacturing specification upon release for distribution.A risk management review found that the reported failure was documented appropriately, and there were no indications to suggest the anticipated risk is not adequate.The provided crf documents have been reviewed, however they did not give any insight into the root cause of the reported left shoulder arthrofibrosis.The requested operative reports and x-ray images were not provided for review.Per the provided case details arthrofibrosis was resolved following the mua.Based on the limited information provided a thorough medical assessment could not be performed.There was no relationship found between the device and the reported event.The complaint was not confirmed.Please refer to the instructions for use for recommendations on proper use of the device and potential troubleshooting methods to prevent future reoccurrence of the reported event.No containment or corrective actions are recommended at this time.If the product associated with this event is returned at a future date, this investigation will be reopened for evaluation.
|
|
Manufacturer Narrative
|
H10: internal complaint reference: (b)(4).
|
|
Event Description
|
It was reported that after an arthroscopic acromioplasty, bursectomy, and distal clavicle excision in which a regeneten bioinductive device was implanted, the patient experienced left shoulder arthrofibrosis.The event was treated with mua and it was resolved.
|
|
Search Alerts/Recalls
|
|
|